Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ASCO

Compugen (NASDAQ:CGEN) said it remains on track to report interim progression-free survival data in the first quarter of 2027 from its MAIA-ovarian study, as the clinical-stage immuno-oncology company outlined first-quarter 2026 results and updates across its internal and partnered programs. On the

MarketBeat

Celcuity Q1 Earnings Call Highlights

Celcuity (NASDAQ:CELC) reported a wider first-quarter loss as the biotechnology company increased spending tied to commercial launch preparations and continued development of gedatolisib, its investigational therapy for hormone receptor-positive, HER2-negative advanced breast cancer. On the company

MarketBeat

Karyopharm Therapeutics Q1 Earnings Call Highlights

Karyopharm Therapeutics (NASDAQ:KPTI) said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofibrosis and an expected midyear readout in endometrial cancer, while reporting higher first-quarter revenue and reaffirming full-year guidance. On th

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Bicara Therapeutics Q1 Earnings Call Highlights

Bicara Therapeutics (NASDAQ:BCAX) said it made progress during the first quarter of 2026 on the development and commercialization strategy for its lead drug candidate, ficerafusp alfa, or FICERA, while reporting a strengthened cash position following a February public offering. On the company’s fir

MarketBeat

Faron Pharmaceuticals To Earn Spotlight At IUIS 2025 With Its Bexmarilimab Data

At IUIS 2025, Dr. Mika Kontro, MD, PhD, will deliver a presentation titled "Efficacy of Macrophage Checkpoint Clever-1 Inhibition with bexmarilimab plus Azacitidine in Myelodysplastic Syndrome: Results from the Ph1/2 BEXMAB Study."

International Business Times

When women are having cancer symptoms dismissed, no wonder they turn to toxic ‘wellness’

LET’S UNPACK THAT: Cancer cases are on the rise in young people but misdiagnosis remains an issue, with everything from anxiety to menopause named as the culprit. Helen Coffey investigates why women in particular are more at risk of having their pain overlooked – and whether mistrust in medicine is…

The Independent UK

2 Biopharmaceutical Stocks Focused on Cancer That Wall Street Predicts Will More Than Double

Analysts are uber bullish on Actuate Therapeutics and PDS Biotechnology stocks for the next 12 months. Here’s why.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Cancer experts warn of coffee enemas and juice diets amid rise in misinformation

Oncologists say patients rejecting proven treatments are dying needlessly because of increase in online ‘cures’

The Guardian - UK

Immunotherapy trial helps cancer patients with tumours live 40% longer

Experts praise groundbreaking results from therapy using genetically modified Car T-cells

The Guardian - UK

How a 1970s Chicano art group defied the mainstream and made history

“ASCO: Without Permission” is director Travis Gutiérrez Senger's latest documentary and executive produced by Gael Garcia Bernal and Diego Luna

The Independent UK

‘Enormous potential’: weight-loss drugs cut cancer risk by a fifth, research shows

Experts believe injections such as Wegovy could play a big role in preventing and treating the disease

The Guardian - UK

Cancer rates among under-50s in UK have risen 24% since 1995, figures show

Increase sharper than in any age group and is likely to be linked to soaring obesity levels, junk food and inactivity, say experts

The Guardian - UK

FDA approves first-of-its-kind new ‘bubble’ treatment for liver cancer

Histotripsy could cause less harmful side effects compared to radiation and chemotherapy, experts say

The Independent UK

FDA proposes ban on certain hair products that have been tied to cancer

FDA officials could ban the products as soon as next spring

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Insider UK

Man in hospital after Peterhead silo explosion

Incident happened at the ASCO supply base in the South Bay area of the town

Daily Record

Man rushed to hospital after Peterhead supply base explosion involving chemicals

Emergency services rushed to the Asco facility at Harbourside in the town at around 11am on Wednesday, June 21.

Daily Record

Explosion rocks supply base in Peterhead sparking emergency response

Workers are said to have been evacuated from the Asco facility at the Harbourside area of the town.

Al Jazeera

New trials show increased survival rates for a range of cancers

A roundup of some of the most promising announcements at a meeting of the American Society of Clinical Oncology.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Global ‘silver tsunami’ of older cancer patients is coming, experts warn

Oncologists sound alarm over risk of healthcare systems buckling due to rising need for specific care

The Guardian - UK

Genetically modifying T-cells cuts blood cancer progression by 74%, trial finds

Therapy slows multiple myeloma in patients who have stopped responding to other treatments, say researchers

The Guardian - UK

Bowel cancer patients could be spared radiotherapy, US study suggests

Doctors found some patients could rely on chemotherapy and surgery alone to treat the disease

The Guardian - UK

Breast cancer drug cuts risk of most common form returning by 25%

Trial results presented at US oncology conference suggest ribociclib could be gamechanging and boost survival rate significantly

Bangkok Post

Brokerages announce downbeat outlook

The total value of securities traded on the Stock Exchange of Thailand is expected to decrease this year from 2022 as concerns about the global economic slowdown and US interest rate hikes affect investor confidence, says the Association of Securities Companies (Asco).

Bangkok Post

SEC urged to rejig rules after MORE scandal

The Association of Securities Companies (Asco) and its members have proposed the Securities and Exchange Commission (SEC) adjust the regulations regarding stock manipulation in the aftermath of the More Return Plc (MORE) scandal.

Benzinga

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ:AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ:MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers." Mereo's lead…

1 2

People

Pakorn Peetathawatchai

Ruenvadee Suwanmongkol

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Securities and Exchange Commission

186 stories

Gilead

185 stories

the University of Pennsylvania

125 stories

Macmillan Cancer Support

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.